A neuronal cell model endogenously expressing the 5-HT,, receptor, in which to study the function and regulation of this gene, has yet to be identified.
We to 5-HT,, agonists in differentiated but not in undifferentiated cells. In order to verify that the large 10.9 kb RNA species in SN-48 cells truly corresponded to the mouse 5-HT,, receptor RNA, a cDNA fragment from differentiated SN-48 cells was used to clone the corresponding mouse brain cDNA. The 2.4 kb cDNA contained a single open reading frame that displayed high (>85% predicted amino acid identity) homology to the human and rat 5-HT,, receptor genes. When transfected into receptor-negative Ltk-cells, this cDNA was found to direct expression of a murine 5-HT,, receptor. Thus, we conclude that upon differentiation SN-48 cells express RNA encoding functional 5-HT,, receptors. The SN-48 septal cells will provide a useful cellular model system for investigating aspects of neuronal differentiation leading to the development of sensitivity to serotonergic input. differentiation, septum, cDNA, , receptor, CAMP] 5Hydroxytryptamine (serotonin, 5-HT) is a neurotransmitter believed to play a role in various cognitive functions such as feeding, sleep, pain, depression, learning, and anxiety (Blier et al., 1987; Charney et al., 1990; Curzon, 1992) . This diversity of actions can be related to the fact that serotonergic neurons send efferents to almost every structure of the brain and especially to the limbic regions (Tork, 1990) . 5-HT actions are mediated via activation of a growing family of 5-HT receptors. This receptor family has been divided into four classes desig-nated 5-HT,, 5-HT,, 5-HT, (Julius, 199 l) , and 5-HT, (Bockaert et al., 1992) on the basis of pharmacological properties, intracellular signaling systems, structural homology, and tissue distribution. The 5-HT, group is the most heterogeneous and is divided into at least four subtypes-5-HT,, (Kobilka et al., 1987; Fargin et al., 1988; Albert et al., 1990 ) 5-HT,, (Voigt et al., 199 1; Jin et al., 1992; Maroteaux et al., 1992) , 5-HT,, (Libert et al., 1989; Hamblin and Metcalf, 199 1; Demchyshyn et al., 1992) , and 5-HT,, (McAllister et al., 1992; Zgombick et al., 1992 )-of which the 5-HT,, subtype has been the most studied for two reasons: first, the availability of a highly selective radioligand (8-OH-DPAT) that allows an extensive biochemical, physiological, and pharmacological characterization of the receptors (Hamon et al., 1987) ; second, the observation that certain 5-HT,, agonists exert anxiolytic and antidepressant effects in clinical paradigms (Blier et al., 1987 (Blier et al., , 1990 .
5-HT,, receptors are expressed in discrete neuronal cell types within the mammalian CNS (e.g., Sotelo et al., 1990) . In fact, radioligand binding studies correlated with in situ hybridization analysis (Chalmers and Watson, 199 1; Pompeiano et al., 1992) indicate that the highest level of expression of the receptor is found in structures such as the dorsal raphe nucleus, septum, hippocampal formation (especially the pyramidal neurons of the CA 1 region and the dentate gyrus), and the entorhinal cortex. The 5-HT,, receptor has been shown to couple negatively to adenylyl cyclase through pertussis toxin (PTx)-sensitive G-proteins (Zgombick et al., 1989; Albert et al., 1990 ) and positively to potassium channels through a different PTx-sensitive G-protein (Innis and Aghajanian, 1987; Innis et al., 1988; Williams et al., 1988; Blier et al., 1993) ; the latter process inducing membrane hyperpolarization and causing a decrease in neuronal firing rate.
To avoid problems of heterogeneity and complexity associated with most brain preparations, neuronal cell lines provide an abundant and homogeneous source of neurons that facilitates the biochemical analysis of various neuron-specific proteins in their natural environment (Blusztajn et al., 1992; Choi et al., 1992) . However, none of these cell lines has been reported to express functional 5-HT,, receptors. Recent progress has led to the construction of cell lines derived from different regions and developmental stages of the CNS (Frederiksen et al., 1988; Lee et al., 1990a,b; Morimoto and Koshland, 1990; Renfranz et al., 199 1; Hales et al., 1992) . We took advantage of hybrid cell lines derived from pre-and postnatal hippocampus and septum, areas richest in 5-HT,, receptors, to screen for cell lines that express the 5-HT,, receptor. We report the characterization of a 5-HT,, receptor from a hybrid cell line (SN-48) derived from 21 d postnatal (P2 1) mouse septal neurons fused with a murine neu-roblastoma (N 18TG2). We also describe the cloning, molecular tibody-antigen complex. Data are presented as mean 2 SEM for tripand pharmacological characterization of the mouse 5-HT,, receptor cDNA.
Materials and Methods
Cell culture. SN-48 (Lee et al., 1990b ) fusion cells were maintained in Dulbecco's modified Eaale's medium (DMEM) suoolemented with 10% (v/v) heat-inactivated fetal calf serum'(FCS) (GIBCO), 2 mM glutamine (GIBCO), and antibiotics (GIBCO) at 37°C in 5% CO,. Differentiation was achieved by plating the cells at a density of 1 O4 cells/cm2 in DMEM supplemented with 1% (v/v) heat-inactivated FCS, 10 PM retinoic acid (RA) (all trans-) (Sigma, St. Louis, MO), and 2 mM glutamine. Ltkmouse fibroblast cells were maintained in a-modified Eagle's medium (a-MEM) supplemented with 10% (v/v) heat-inactivated FCS and antibiotics at 37°C in 5% CO,.
Polymerase chain reaction and cDNA cloning. The 9 18 base pair (bp) fragment from reverse-transcription polymerase chain reaction (RT-PCR) of differentiated SN-48 5-HT,, mRNA was obtained as follows: total cytoplasmic RNA was isolated from 48 hr differentiated SN-48 as described (Sambrook et al., 1989) . RNA (0.3 pg) was reverse-transcribed with Superscript (GIBCO/Bethesda Research Labs) using random hexamers (Pharmacia). An aliquot of the resulting cDNA was used as template during the subsequent PCR amplification with sense oligonucleotide (#45, and antisense oligonucleotide (#44, 5'-GGGAGTTGGAGTAGCCTAGCC-3') derived from sequences of the second and seventh predicted transmembrane domains of the rat and human 5-HT,, receptor genes. The 918 bp product of the amplification was isolated, and cloned into the EcoRV site of pBluescript KS+ (Stratagene). This 918 bp fragment was then radiolabeled using a random-primed labeling kit (Boehringer Mannheim). An 1 I-d-old NIH Swiss mouse brain Xgt 11 cDNA library (constructed by J. Kamholz, C. Puckett, and R. A. Lazzarini, NINCDS) was probed at high stringency with the radiolabeled 9 18 bp fragment as described elsewhere (Sambrook et al., 1989 ) and a single clone (clone A) containing a 2.4 kilobase (kb) cDNA insert was isolated and subcloned into the EcoRI site of DBhCSCriDt KS+. Both strands of the cDNA insert were sequenced by the Sanger method using a T7 polymerase-based DNA sequencing kit (Pharmacia).
Stable eukaryotic expression. The 2.4 kb EcoRI fragment of clone A was subcloned into EcoRI-cut pcDNA eukaryotic expression vector (InVitrogen), and 20 pg was cotransfected by the calcium phosphate method (Sambrook et al., 1989) with 2 pg of pRSV-neo plasmid. Clones were selected in medium containing 500 &ml of G418 (Geneticin, GIBCO) and screened for expression of the transfected 5-HT,, receptor by RT-PCR (see above). Positive clones were further screened for level of functional receptors by measurement of calcium release from intracellular pools upon activation of the receptors as described previously (Liu and Albert, 1991) . One clone (LMl A-5) was selected for further characterization.
Radioligand binding studies. Membranes from the positive LM l A-5 clone were harvested and assayed for binding as described previously (Albert et al., 1990 ) using 3H-8-OH-2-(di-n-propylamino)1,2,3,4-tetrahydronaphthalene OH-8-OH-DPAT) (Amersham) as ligand, and 10 PM 5-HT to determine nonspecific binding. The results were analyzed by the LIGAND computer software (Biosoft Cambridge, UK). Specific 3Hl 8-OH-DPAT binding was not detected in nontransfected Ltkm cells or nondifferentiated SG48 cells (data not shown). Attempts to demonstrate specific 3H-8-OH-DPAT binding in differentiated SN-48 cells were unsuccessful, partly because of low cell number and low proportions of differentiated cells in large preparations.
CAMP assay. Measurement of CAMP was performed as described elsewhere (Albert et al., 1990) . In brief, SN-48 cells were differentiated in six-well 35 mm dishes; medium was changed 24 hr prior to experimentation. After removal of the medium, cells were incubated in 1 ml of serum-free medium containing 100 PM 1 -methyl-3-isobutylxanthine (IBMX) (Sigma, St. Louis, MO) with the various test compounds for 20 min at room temperature. The medium was discarded and the cells were lysed by addition of 1 ml of serum-free medium containing 0.05% of Triton X-100 and 100 PM IBMX. The media were collected and centrifuged (2000 x g, 5 min), and the supematant was assayed for CAMP. CAMP was assayed by a specific radioimmunoassay (ICN) as described previously (Albert et al., 1990) with antibody used at 1:500 dilution. After 16 hr of incubation at 4°C 20 ~1 of 10% BSA and 1 ml of ice-cold 95% ethanol were added sequentially to precipitate the anlicate wells.
Northern blot analysis. Total RNA (extracted from differentiated and nondifferentiated SN-48 cells, and from LMl A-5 cells), polyA+ selection of mRNA species, and Northern blot analysis were performed as described (Sambrook et al., 1989) . Molecular weight was extrapolated from the semilogarithmic relation to migration using molecular weight standards.
Results and Discussion
A neuroblastoma x septum hybrid cell line expressing the 5-HT,, receptor
The characterization of neuronal hybrid cells derived from the fusion of primary cultures of pre-and postnatal hippocampal and septal neurons with a neuroblastoma cell line (N 18TG2) has been described (Lee et al., 1990a,b (Fig. la) . However, 48 hr of treatment with 10 KM RA (see Materials and Methods) resulted in neuronal differentiation, as assessed by the appearance of long, {axon-like processes (Fig.  lb) . Since the concentration of RA used was not toxic to the cells, the differentiation observed is induced and not due to selection of a minor population of differentiated cells preexisting within the undifferentiated population. Concomitant with the morphological change, the appearance of mRNA encoding the 5-HT,, receptor was observed by Northern blot analysis ofRNA harvested from cells differentiated for 48 hr, but absent from nondifferentiated SN-48 cells (Fig. 2) . The temporal association of enhanced levels of receptor RNA with the development of a neuronal phenotype suggested that the increase in 5-HT,, receptor RNA may be due to indirect differentiation-inducing actions of RA that result in neurons capable of expressing the receptor, although a direct action of RA on receptor gene transcription was not ruled out. The size of the 5-HT,, receptor RNA present in the differentiated SN-48 cells (10.9 kb) is larger than species observed for the rat and human receptor RNAs. Northern blot analysis of rat brain tissues detects three message sizes (3.9, 3.6, and 3.3 kb) encoding the 5-HT,, receptor and analysis of fetal human peripheral tissues demonstrate a receptor mRNA species of -6.0 kb (Kobilka et al., 1987; Albert et al., 1990) . These differences in size between the three species appear to result from variation in the lengths of untranslated regions of the RNA.
Functional characterization of the SHT,, receptors
In order to determine whether the increase in 5-HT,, receptor mRNA that precedes morphologic neuronal differentiation was associated with expression of function responses to 5-HT,, receptor activation in SN-48 cells, actions of receptor activation on intracellular CAMP accumulation were tested (see Materials and Methods). In the nondifferentiated SN-48 cells, and to a lesser extent in differentiated cells, both vasoactive intestinal peptide (VIP) and prostaglandin E, (PGE,) markedly elevated basal CAMP levels (Fig. 3A) . The 5-HT,, receptor agonist g-OH-DPAT had no effect on basal or on VIP-or PGE,-stimulated CAMP accumulation in the nondifferentiated cells, even at high Figure 3 . 5-HT,,-mediated inhibition of stimulated CAMP accumulation. Each experiment is representative of three independent assays. A, Inhibitory action of I-OH-DPAT (10 PM) on stimulation of CAMP levels by PGE, or VIP in nondifferentiated, differentiated, and PTxpretreated/differentiated SN-48 cells. PTx (250 rig/ml) was added to differentiated cells 16 hr prior to assay, and the other compounds were present at the indicated concentrations during the assay. The data are presented as the mean f SEM of three determinations from individual wells of n-fold increase over basal CAMP level. The basal CAMP levels (pmol/well) for nondifferentiated, differentiated, and differentiated/PTx were 3.0 + 0.7,0.73 ? 0.032, and 0.94 +-0.10, respectively. Student's t test comparing PGE*-or VIP-stimulated samples in the absence and presence of 8-OH-DPAT are designated *, p < 0.02; **, p < 0.01; the significance of other data points is readily apparent. B, Dose dependency of 8-OH-DPAT-induced inhibition of PGE,-stimulated CAMP levels. Data are presented as percentage of the CAMP level in the presence of 10 PM PGE, alone. The basal and PGE,-treated CAMP levels were 1.8 ? 0.14 and 7.5 + 0.9 pmol/well. The data represent mean f. SEM of three determinations from individual wells. Statistically significant differences from PGE,-stimulated samples using Student's t test are indicated as *, p < 0.05; **, p < 0.01. GCG  GTG  GGG  ACT  CCG  TGC  GCT  AAT  GGG  GCG  GTG  AGA  CAG  GGT  GAG  GAC  GAC  GCC  ACC  CTG  GAG  GTG  ATC  GAG  GTG  CAT  CGA  GTG  GGC AAA  GGG  GAC  CTT  CCT  CTG  CCC  AGC  GM  TCA  GGA  GCT  ACC  TX  TAT  GTC  CCC  GCC  TGC  TTG  GAG  AGA  AAA  AAT  GAG  CGC  ACT  GCT TTT  TTC  ATT  GTG  GCG  CTG  GTC  CTA  'XT  TTC  TGT  GAG  AGC  AGT  TGC  CAC  ATG  CCT  GAG  TTG  TTG  GGT  GCC  ATA  ATT  AAC  TGG  CTA  GGC TCC  AAC  TCC  CTG  CTC  AAC  CCA  GTT  ATT  TAT  GCT  TAT  TTC  AAC  MA  GAC  TTT  CAA  AAC  GCT  TTT  AAG  AAG  AK  ATC  AAG  TGC  RAG  TTC  TGC   ?. Figure 5 . Schematic representation of the murine S-HT,, receptor. A hypothetical model of the 5-HT,, receptor based on hydropathicity analysis and structural evidence from other G-protein-coupled receptors is shown. The amino acid residues that differ from the rat and/or human receptor sequences are indicated. Putative N-linked glycosylation sites are indicated by small arboreous symbols.
( Fig. 2) . In contrast, the nondifferentiated cells apparently express PGE, and VIP receptors. However, in the differentiated state, 8-OH-DPAT significantly decreased both the VIP-and the PGE,-stimulated levels of CAMP by 54% and 37%, respectively (Fig. 3A) . This inhibition is mediated through PTx-sensitive G-proteins since 16 hr ofpretreatment of the differentiated SN-48 cells with 250 r&ml of PTx completely abolished the 8-OH-DPAT-mediated inhibition of stimulated CAMP accumulation (Fig. 3A) . PTx pretreatment did not, however, exert any effect in the undifferentiated cells (data not shown).
In order to determine whether the inhibitory actions of 10 PM 8-OH-DPAT are mediated by a 5-HT,,-like receptor, reduced concentrations of 8-OH-DPAT were shown to inhibit PGE,-stimulated CAMP levels in differentiated SN-48 cells (Fig.  3B) , with a maximal inhibition identical to that obtained with 10 PM 8-OH-DPAT (Fig. 3A) . In three independent experiments, 8-OH-DPAT inhibited PGE,-induced CAMP accumulation with an EC,, value of 20 f 5 nM. At the lowest concentration examined (1. nM), 8-OH-DPAT appeared to enhance slightly PGE,-induced CAMP accumulation; however, this change was not statistically significant. The estimated EC,, value for inhibition of CAMP levels by 8-OH-DPAT is consistent with the values of lo-20 nM obtained for the mouse hippocampal (Dumuis et al., 1988) or the cloned rat 5-HT,, receptors (Liu and Albert, 199 1; Fowler et al., 1992) , and supports the 5-HT,,-like nature of the receptor in differentiated SN-48 cells.
These results correlate with the increase in 5-HT,, receptor mRNA levels, and strongly suggest that differentiated SN-48 cells express functional 5-HT,, receptors that are coupled to c PTx-sensitive G-proteins to inhibit adenylyl cyclase. The GABAergic phenotype of these cells is consistent with the recent observation that 5-HT,, receptors are located on certain GABAergic neurons of the rat septum (Pompeiano et al., 1992) , the neurons from which the SN-48 cells may be derived.
Cloning of a murine SHT,, receptor cDNA
Because of the large size of the mouse 5-HT,, receptor mRNA, we wished to determine the nature of the coding sequence in SN-48 and mouse brain. A 918 bp fragment was isolated by RT-PCR of RNA from the differentiated SN-48 cells using primers specific for the 5-HT,, receptor. The cloned RT-PCR fragment had striking similarity to corresponding regions of the rat and human 5-HT,, receptor genes, and was identical to an analogously isolated fragment from mouse hippocampus total RNA (data not shown). Using this fragment as a probe, a P18 mouse brain Xgt 11 cDNA library was screened under high stringency and a single clone containing a 2.4 kb cDNA insert (clone A) was isolated and sequenced (Fig. 4) . The sequence of clone A contained a single open reading frame encoding a 42 1 amino acid residue protein with a predicted molecular weight of 46 kDa. Analysis of clone A revealed a region with identity (100%) to sequences derived from the 9 18 bp RT-PCR fragments from mouse brain and differentiated SN-48 cells (data not shown).
The overall sequence homology with the rat and human 5-HT,, receptor gene (nucleotide : amino acid) was as follows: mouserat: 93:94%; mouse-human: 80:86%. Computer-aided hydrophobicity analysis of the predicted amino acid composition of clone A indicated the presence of seven hydrophobic domains with the potential of forming transmembrane cr-helices (Fig. 5 ) consistent with the structure predicted for G-protein<oupled receptors (Caron and Lefkowitz, 1991) . Sporadic amino acid differences were localized in regions of the receptor that have low conservation between human and rat homologs (e.g., the amino-terminal and the central portion of the third cytoplasmic loop), consistent with species differences observed in other G-protein<oupled receptors. The strong overall sequence similarity between clone A and the rat and human 5-HT,, receptors suggested that clone A encodes the mouse 5-HT,, receptor. In order to substantiate this hypothesis, radioligand binding assays were performed.
Clone A was subcloned into a mammalian expression vector and stably transfected in mouse Ltk-fibroblast cells as described in Materials and Methods. Membranes prepared from the cloned cells LM l A-5 exhibited binding features characteristic of 5-HT,, receptors. Scatchard analysis of saturation binding experiments using )H-8-OH-DPAT as ligand indicated a single site with KD of 1.68 nM f 0.36 (Fig. 6 ) similar to the value (0.8 nM) obtained for the cloned rat 5-HT,, receptor (Albert et al., 1990) . Moreover, ligand binding competition experiments demonstrated the same rank order of potency as observed for the rat and human 5-HT,, receptors for the following compounds: 8OH-DPAT > 5-HT > spiroxatrine > spiperone. Thus, clone A encodes a murine 5-HT,, receptor.
Conclusion
Based on the pharmacological profile exhibited by clone A when expressed heterologously in mammalian cultured cells, as well as its strong homology with the human and rat 5-HT,, receptors, we conclude that clone A encodes the mouse 5-HT,, receptor cDNA. In addition, we have identified an inducible neuronal cell line that expresses endogenously the murine 5-HT,, receptor upon morphological differentiation. This cell line represents an excellent model system to investigate the natural environment in which the 5-HT,, receptor exerts its actions. Moreover, the SN-48 cells provide a powerful paradigm for investigating the aspects of neuronal differentiation leading to the development of sensitivity to serotonergic input through 5-HT,, receptors.
